Grever MR - Search Results

1

Queuine, a tRNA anticodon wobble base, maintains the proliferative and pluripotent potential of HL-60 cells in the presence of the differentiating agent 6-thioguanine.

French BT, Patrick DE, Grever MR, Trewyn RW. French BT, et al. Among authors: grever mr. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):370-4. doi: 10.1073/pnas.88.2.370. Proc Natl Acad Sci U S A. 1991. PMID: 1988936 Free PMC article.

2

Differential effect of 6-ethylmercaptopurine on c-myc expression in wild-type and HGPRT-deficient HL-60 cells.

French BT, Patrick DE, Grever MR, Trewyn RW. French BT, et al. Among authors: grever mr. Cancer Chemother Pharmacol. 1990;27(3):171-7. doi: 10.1007/BF00685709. Cancer Chemother Pharmacol. 1990. PMID: 2265452

3

Urinary nucleosides in leukemia: laboratory and clinical applications.

Trewyn RW, Grever MR. Trewyn RW, et al. Among authors: grever mr. Crit Rev Clin Lab Sci. 1986;24(1):71-93. doi: 10.3109/10408368609111597. Crit Rev Clin Lab Sci. 1986. PMID: 3539520 Review.

4

Differential excretion of modified nucleosides in adult acute leukemia.

Heldman DA, Grever MR, Trewyn RW. Heldman DA, et al. Among authors: grever mr. Blood. 1983 Feb;61(2):291-6. Blood. 1983. PMID: 6571786 Free article.

5

Urinary excretion of modified nucleosides in chronic myelogenous leukemia.

Heldman DA, Grever MR, Speicher CE, Trewyn RW. Heldman DA, et al. Among authors: grever mr. J Lab Clin Med. 1983 May;101(5):783-92. J Lab Clin Med. 1983. PMID: 6572681

6

Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia.

Heldman DA, Grever MR, Miser JS, Trewyn RW. Heldman DA, et al. Among authors: grever mr. J Natl Cancer Inst. 1983 Aug;71(2):269-73. J Natl Cancer Inst. 1983. PMID: 6576186

7

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.

Blum W, Garzon R, Klisovic RB, Schwind S, Walker A, Geyer S, Liu S, Havelange V, Becker H, Schaaf L, Mickle J, Devine H, Kefauver C, Devine SM, Chan KK, Heerema NA, Bloomfield CD, Grever MR, Byrd JC, Villalona-Calero M, Croce CM, Marcucci G. Blum W, et al. Among authors: grever mr. Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7473-8. doi: 10.1073/pnas.1002650107. Epub 2010 Apr 5. Proc Natl Acad Sci U S A. 2010. PMID: 20368434 Free PMC article. Clinical Trial.

8

A comprehensive phase I and II clinical investigation of fludarabine phosphate.

Grever M, Leiby J, Kraut E, Metz E, Neidhart J, Balcerzak S, Malspeis L. Grever M, et al. Semin Oncol. 1990 Oct;17(5 Suppl 8):39-48. Semin Oncol. 1990. PMID: 1699282 Clinical Trial.

9

Phase I clinical investigation of fludarabine phosphate by a loading-dose and continuous-infusion schedule.

Leiby JM, Grever MR, Staubus AE, Neidhart JA, Malspeis L. Leiby JM, et al. Among authors: grever mr. J Natl Cancer Inst. 1988 May 18;80(6):447-9. doi: 10.1093/jnci/80.6.447. J Natl Cancer Inst. 1988. PMID: 2452888

10

Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.

Grever MR, Kopecky KJ, Coltman CA, Files JC, Greenberg BR, Hutton JJ, Talley R, Von Hoff DD, Balcerzak SP. Grever MR, et al. Nouv Rev Fr Hematol (1978). 1988;30(5-6):457-9. Nouv Rev Fr Hematol (1978). 1988. PMID: 2464793

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters